DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Portola Pharmaceuticals, I.
Portola pharmaceuticals receives complete response letter from FDA for biologics license application for AndexXa™ (andexanet alfa).
2016
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.